Llwytho...
Research Progress on Resistance Mechanisms and Overcoming Strategies to Third-generation EGFR-TKIs in Advanced Non-small Cell Lung Cancer
Targeted therapy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs) has been the standard modality as the first-line treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC). The first- and second-generation EGFR-TKIs have shown significant efficacy in NSCLC patie...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Chinês |
| Cyhoeddwyd: |
Magazine House of Cancer Research on Prevention and Treatment
2019-10-01
|
| Cyfres: | Zhongliu Fangzhi Yanjiu |
| Pynciau: | |
| Mynediad Ar-lein: | http://html.rhhz.net/ZLFZYJ/html/8578.2019.19.0169.htm |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|